Papers - Kurose Kouichi

Development of RT h-CLAT, a Rapid Assessment Method for Skin Sensitizers Using THP-1 Cells as a Biosensor

Hiroki Koyama, Ayami Maeda, Peiqi Zhai, Keiichiro Koiwai, Kouichi Kurose , 2024.12

Biosensors

DOI

A highly sensitive detection of salmonids by real-time PCR targeting salmonid-specific retrotransposon Hpa I element

Wei Cui, Yuya Negoro, Hiroki Koyama, Kouichi Kurose , 2024

Fisheries Science

DOI

Rapid and specific detection of mackerels of the genus Scomber using loop-mediated isothermal amplification (LAMP)

Wei Cui, Hiroki Koyama, Kouichi Kurose , 2024

Fisheries Science

DOI

A newly identified enzyme from Japanese common squid Todarodes pacificus has the ability to biosynthesize d-aspartate.

Hiroki Koyama, Yui Takahashi, San Matori, Hisato Kuniyoshi, Kouichi Kurose , 2023.11

Archives of biochemistry and biophysics

DOI

Comprehensive and species-specific detection of mackerels of the genus Scomber in processed foods using SYBR Green-based real-time PCR

Wei Cui, Yuki Sano, Hiroki Koyama, Kouichi Kurose , 2023.10

Fisheries Science

DOI

Identification of gene expression markers and development of evaluation method using cell-based and RT-PCR-based assay for skin sensitising potential of chemicals.

Maho Ukaji Nishikawa, Megumi Iwaki, Kosuke Tashiro, Kouichi Kurose , 2020.09

Xenobiotica; the fate of foreign compounds in biological systems

DOI

Study on the fatty acid compositions of deep-sea isopod Bathynomus doederleinii

Takayuki Sawasaki, Kigen Takahashi, Kouichi Kurose, Emiko Okazaki and Kazufumi Osako , 2017.10

The JSFS 85th Anniversary-Commemorative International Symposium “Fisheries Science for Future Generations” Symposium Proceedings

クラゲによるアレルギーの1成人例

鈴木 慎太郎, 宮田 祐人, 神野 恵美, 岸野 康成, 本間 哲也, 大田 進, 田中 明彦, 横江 琢也, 大西 司, 相良 博典, 倉田 なおみ, 嶋倉 邦嘉, 黒瀬 光一 , 2017.09

アレルギー

アルカリ塩水晒しによるアカアマダイBranchiostegus japonicus筋肉加熱ゲル形成能の改善

髙橋 希元, 黒瀬 光一, 岡﨑 惠美子, 大迫 一史 , 2017.09

日本水産学会誌

A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients

Sai, K. .....Kurose, K. et al. , 2016.12

Drug Metabolism and Pharmacokinetics

Effect of various protease inhibitors on heat-induced myofibrillar protein degradation and gel-forming ability of red tilefish (Branchiostegus japonicus) meat

Kigen Takahashi, Koichi Kurose, Emiko Okazaki, Kazufumi Osako , 2016.05

LWT - Food Science and Technology

Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese

K Maekawa, R Nakamura, N Kaniwa, Seiho Mizusawa, Aya Kitamoto, Takuya Kitamoto, M Ukaji, Y Matsuzawa, E Sugiyama, Y Uchida, Kouichi Kurose, et al. , 2015.10

Pharmacogenomics

Generation of Enterocyte-Like Cells with Pharmacokinetic Functions from Human Induced Pluripotent Stem Cells Using Small-Molecule Compounds.

Takahiro Iwao, Nao Kodama, Yuki Kondo, Tomoki Kabeya, Katsunori Nakamura, Takashi Horikawa, Takuro Niwa, Kouichi Kurose, and Tamihide Matsunaga , 2015.02

Drug Metab Pharmacokinet

Selective Culture Method for Hepatocyte-like Cells Differentiated from Human Induced Pluripotent Stem Cells.

Kondo Y, Yoshihashi S, Mimori K, Ogihara R, Kanehama Y, Maki Y, Enosawa S, Kurose K, Iwao T, Nakamura K, Matsunaga T. , 2014.10

Drug Metab Pharmacokinet.

Histone Deacetylase Inhibitor Valproic Acid Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells

Kondo Y, Iwao T, Yoshihashi S, Mimori K, Ogihara R, Nagata K, Kurose K, Saito M, Niwa T, Suzuki T, Miyata N, Ohmori S, Nakamura K, Matsunaga T. , 2014.08

PLoS One

Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses

Kimie Sai, K Kurose, T Koizumi, N Katori, J Sawada,Y Matsumura, N Saijo, N Yamamoto, T Tamura, H Okuda,Y Saitoa , 2014.01

Biological & Pharmaceutical Bulletin

GWASを用いた副作用リスク因子マーカーの網羅的解析

黒瀬光一，鹿庭なほ子，斎藤嘉朗 , 2013.10

臨床薬理

市販後安全性確保に係わるバイオマーカーと診断

斎藤嘉朗、前川京子、田島陽子、児玉進、黒瀬光一 , 2013.09

レギュラトリーサイエンス学会誌

A whole-genome association study of major determinants for allopurinol-related Stevens- Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z. , 2013.09

Pharmacogenomics J.

Specific HLA types are associated with anti-epileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in the Japanese

N Kaniwa, E Sugiyama, Y Saito, K Kurose1, K Maekawa1, R Hasegawa, H Furuya, H Ikeda, Y Takahashi, M Muramatsu, M Tohkin, T Ozeki, T Mushiroda, M Kubo, N Kamatani, M Abe, A Yagami , M Ueta, C Sotozono, S Kinoshita, Z Ikezawa, K Matsunaga, M Aihara, and the Japan Pharmacogenomics Data Science Consortium , 2013.09

Pharmacogenomics

副作用バイオマーカーの探索と臨床応用研究の現状について

斎藤嘉朗，中村亮介，黒瀬光一 , 2013.09

臨床病理レビュー

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

Kurose K, Sugiyama E, Saito Y. , 2012.09

Drug Metab Pharmacokinet.

Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese

Maekawa K, Nishikawa J, Kaniwa N, Sugiyama E, Koizumi T, Kurose K, et al. , 2012.09

Drug Metab Pharmacokinet.

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression

Kurose K, Hiratsuka K, Ishiwata K, et al. , 2012.09

Psychiatry Res.

Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant

Tada M, Ishii-Watabe A, Maekawa K, Fukushima-Uesaka H, Kurose K,et al. , 2012.09

Immunogenetics

Quality requirements for genomic DNA preparations and storage conditions for a high-density oligonucleotide microarray

Kurose K, Koizumi T, Nishikawa J, Maekawa K, Saito Y. , 2012.09

Biol Pharm Bull.

ゲノム情報に基づいた副作用予測.

黒瀬光一，斎藤嘉朗 , 2012.02

日本臨牀

Genetic variation and haplotype structures of the glutathione S-transferase genes, GSTA1 and GSTA2 in Japanese colorectal cancer patients.

Maekawa K, Hamaguchi T, Saito Y, Tatewaki N, Kurose K, Kaniwa N, Nakajima TE, Kato K, Yamada Y, Shimada Y, Yoshida T, Kamatani N, Ura T, Saito M, Muro K, Fuse N, Yoshino T, Doi T, Otsu A, Saijo N, Sawada J, Okuda H, Matsumura Y. , 2011.09

Drug Metab. Pharmacokinet.

Functional analysis of genetic variations in the 5'-flanking region of the human MDR1 gene.

Saeki M, Kurose K, Hasegawa R, Tohkin M , 2011.09

Molecular Genetics and Metabolism

Genetic polymorphisms and haplotypes of POR, encoding cytochrome P450 oxidoreductase, in a Japanese population

Saito Y, Yamamoto N, Katori N, Maekawa K, Fukushima-Uesaka H, Sugimoto D, Kurose K, Sai K, Kaniwa N, Sawada J, Kunitoh H, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Okuda H, Tamura T. , 2011.09

Drug Metab. Pharmacokinet.

Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.

Katori N, Sai K, Saito Y, Fukushima-Uesaka H, Kurose K, Yomota C, Kawanishi T, Nishimaki-Mogami T, Naito M, Sawada J, Kunitoh H, Nokihara H, Sekine I, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Yamamoto N, Okuda H, Tamura T. , 2011.09

J. Pharm. Sci.

Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis.

Ishii-Watabe A, Saito Y, Suzuki T, Tada M, Ukaji M, Maekawa K, Kurose K, Kaniwa N, Sawada J, Kawasaki N, Yamaguchi T, Eguchi Nakajima T, Kato K, Yamada Y, Shimada Y, Yoshida T, Ura T, Saito M, Muro K, Doi T, Fuse N, Yoshino T, Ohtsu A, Saijo N, Hamaguchi T, Okuda H, Matsumura Y , 2010.09

Drug Metab. Pharmacokinet.

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R, JSAR research group. , 2010.09

Epilepsia

Prediction of severe adverse drug reactions from pharmacogenetic biomarkers, drug metabolism and pharmacokinetics.

Tohkin M, Ishiguro A, Kaniwa N, Saito Y, Kurose K, Hasegawa R , 2010.09

Drug Metab. Pharmacokinet.

Genetic polymorphisms of copper- and platinum drug- efflux transporters ATP7A and ATP7B in Japanese cancer patients.

Fukushima-Uesaka H, Saito Y, Maekawa K, Kurose K, Sugiyama E, Katori N, Kaniwa N, Hasegawa R, Hamaguchi T, Eguchi-Nakajima T, Kato K, Yamada Y, Shimada Y, Yoshida T, Yamamoto N, Nokihara H, Kunitoh H, Ohe Y, Tamura T, Ura T, Saito M, Muro K, Doi T, Fuse N, Yoshino T, Ohtsu A, Saijo N, Matsumura Y, Okuda H, Sawada J. , 2009.09

Drug Metab. Pharmacokinet.

Genetic variations and haplotype structures of the glutathione S-transferase genes, GSTT1 and GSTM1, in a Japanese patient population.

Tatewaki N, Maekawa K, Katori N, Kurose K, Kaniwa N, Yamamoto N, Kunitoh H, Ohe Y, Nokihara H, Sekine I, Tamura T, Yoshida T, Saijo N, Saito Y, Sawada J. , 2009.09

Drug Metab. Pharmacokinet.

Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population

Sai K, Saito Y, Itoda M, Fukushima-Uesaka H, Nishimaki-Mogami T, Ozawa S, Maekawa K, Kurose K, et al. , 2008.09

Drug Metabolism and Pharmacokinetics

Importance of UDP-glucuronosyltransferase 1A1 *6 for irinotecan toxicities in Japanese cancer patients.

Sai K, Saito Y, Sakamoto H, Shirao K, Kurose K, et al. , 2008.09

Cancer Lett.

Thyroid hormone receptor mediates human MDR1 gene expression — identification of the response region essential for gene expression

Kurose K, Saeki M, Tohkin M, Hasegawa R , 2008.09

Archives of Biochemistry and Biophysics

Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients

Sai K, Saito Y, Fukushima-Uesaka H, Kurose K, et al. , 2008.09

Cancer Chemother. Pharmacol.

Identification of the functional vitamin D response elements in the human MDR1 gene.

Saeki M, Kurose K, Tohkin M, Hasegawa R , 2008.09

Biochemical Pharmacology

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens- Johnson syndrome and toxic epidermal necrolysis.

Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, et al. , 2008.09

Pharmacogenomics

Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects : SLCO1B1*17 is more prevalent than *15.

Kim SR, Saito Y, Sai K, Kurose K, et al. , 2007.09

Drug Metab. Pharmacokinet.

Difference in nucleocytoplasmic shuttling sequences of rat and human constitutive active/androstane receptor.

Kanno Y, Suzuki M, Miyazaki Y, Matsuzaki M, Nakahama T, Kurose K, et al. , 2007.09

Biochim. Biophys. Acta

CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population.

Saito Y, Katori N, Soyama A, Nakajima Y, Yoshitani T, Kim SR, Fukushima-Uesaka H, Kurose K, et al. , 2007.09

Pharmacogenet. Genomics

Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences

Maekawa K, Saeki M, Saito Y, Ozawa S, Kurose K, et al. , 2007.09

J. Hum. Genet.

Fourteen novel genetic variations and haplotype structures of the TYMS gene encoding human thymidylate synthase (TS).

Kim SR, Ozawa S, Saito Y, Kurose K, et al. , 2006.09

Drug Metab. Pharmacokinet.

Identification of regulatory sites in the human PXR (NR1I2) promoter region.

Kurose K, Ikeda S, Koyano S, Tohkin M, Hasegawa R, Sawada J. , 2006.09

Molecular and Cellular Biochemistry

Haplotype structures of the UGT1A gene complex in a Japanese population.

Saeki M, Saito Y, Jinno H, Sai K, Ozawa S, Kurose K, et al. , 2006.09

Pharmacogenomics J.

Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer.

Nakajima Y, Yoshitani T, Fukushima-Uesaka H, Saito Y, Kaniwa N, Kurose K, et al. , 2006.09

Clin. Pharmacol. Ther.

Genetic variations and haplotype structures of the ABCB1 gene in a Japanese population: an expanded haplotype block covering the distal promoter region, and associated ethnic differences.

Sai K, Itoda M, Saito Y, Kurose K, et al. , 2006.09

Ann. Hum. Genet.

Transcription factor NF2d9 (LBP-1a) interacts with the positive regulatory element for the xenobiotic responsive element.

Kurose K, Tohkin M, Hasegawa R. , 2005.09

Biochim. Biophys. Acta

Novel genetic polymorphisms in the NR3C1 (glucocorticoid receptor) gene in a Japanese population.

Koyano S, Saito Y, Sai K, Kurose K, et al. , 2005.09

Drug Metab. Pharmacokinet.

Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C>T (P229L) found in an African- American.

Kaniwa N, Kurose K, et al. , 2005.09

Drug Metab. Dispos.

5’ Diversity of human hepatic PXR (NR1I2) transcripts and identification of the major transcription initiation site.

Kurose K, Koyano S, Ikeda S, Tohkin M, Hasegawa R, Sawada J. , 2005.09

Molecular and Cellular Biochemistry

Functional analysis of four naturally occurring variants of human constitutive androstane receptor.

Ikeda S, Kurose K, et al. , 2005.09

Molecular Genetics and Metabolism

Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population.

Fukushima-Uesaka H, Saito Y, Watanabe H, Shiseki K, Saeki M, Nakamura T, Kurose K, et al. , 2004.09

Human Mutation

Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region.

Koyano S, Kurose K, et al. , 2004.09

Drug Metab. Dispos.

Twenty-six novel single nucleotide polymorphisms and their frequencies of the NR1I3 (CAR) gene in a Japanese population.

Ikeda S, Kurose K, et al. , 2003.09

Drug Metab. Pharmacokinet.

Bisphenol A induces apoptosis in central neural cells during early development of Xenopus laevis.

Oka T, Adati N, Shinkai T, Sakuma K, Nishimura T, Kurose K. , 2003.09

Biochem. Biophys. Res. Commun.

Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing.

Saeki M, Saito Y, Jinno H, Tohkin M, Kurose K, et al. , 2003.09

Clin. Chem.

Eleven novel single nucleotide polymorphisms in the NR1I2 (PXR) gene, four of which induce non-synonymous amino acid alterations.

Koyano S, Kurose K, et al. , 2002.09

Drug Metab. Pharmacokinet.

Molecular cloning and characterization of three novel cytochrome P450 2D isoforms, CYP2D20, CYP2D27, and CYP2D28 in the Syrian hamster (Mesocricetus auratus).

Oka T, Fukuhara M, Ushio F, Kurose K. , 2000.09

Comparative Biochemistry and Physiology, Part C

Cloning and expression analysis of a new member of the cytochrome P450, CYP2A15 from the Chinese hamster, encoding testosterone 7α-hydroxylase.

Kurose K, Isozaki M, Tohkin M, Fukuhara M. , 1999.09

Archives of Biochemistry and Biophysics

A novel positive regulatory element that enhances hamster CYP2A8 gene expression mediated by xenobiotic responsive element.

Kurose K, Tohkin M, Fukuhara M. , 1999.09

Molecular Pharmacology

Molecular cloning, heterologous expression, and characterization of a novel member of CYP2A in the Syrian hamster.

Tohkin M, Kurose K, Isozaki M, Fukuhara M. , 1999.09

Biochim. Biophys. Acta

A major phenobarbital- inducible P450 isozyme, CYP2A14 in the Chinese hamster liver: purification, characterization, and cDNA cloning.

Fukuhara M, Kurose K, et al. , 1998.09

Archives of Biochemistry and Biophysics,

Cloning and characterization of Syrian hamster testosterone 7α-hydroxylase, CYP2A9.

Kurose K, Tohkin M, Ushio F, Fukuhara M. , 1998.09

Archives of Biochemistry and Biophysics

cDNA cloning and expression of a novel CYP3A from the Syrian hamster, CYP3A31.

Alabouch S, Kurose K, et al. , 1998.09

Biochim. Biophys. Acta

Okadaic acid potentiates 3-methylcholanthrene-induced CYP2A8 gene expression in primary cultures of Syrian hamster hepatocytes: possible involvement of activator protein-1.

Tohkin M, Kurose K, Fukuhara M. , 1996.09

Molecular Pharmacology

RNA polymerase III dependence of the human L1 promoter and possible participation of the RNA polymerase II factor YY1 in the RNA polymerase III transcription system.

Kurose K, Hata K, Hattori M, Sakaki Y. , 1995.09

Nucleic Acids Research

Amyloidogenic and non-amyloidogenic transthyretin Asn 90 variants.

Alves IL, Almeida MR, Skare J, Skinner M, Kurose K, Sakaki Y, Costa PP, Saraiva MJM. , 1992.09

Clinical Genetics

Identification of an internal cis-element essential for the human L1 transcription and a nuclear factor(s) binding to the element.

Minakami R, Kurose K, Etoh K, Furuhata Y, Hattori M, Sakaki Y. , 1992.09

Nucleic Acids Research

Bioluminescence of the Ca2+-binding photoprotein aequorin after cystein modification.

Kurose K, Inouye S, Sakaki Y, Tsuji FI. , 1989.09

Proc. Natl. Acad. Sci. USA